Zobrazeno 1 - 10
of 846
pro vyhledávání: '"Szuber, N."'
Autor:
Szuber N; Department of Hematology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada., Orazi A; Department of Pathology, Texas Tech University Health Sciences Center, El Paso, Texas, USA., Tefferi A; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Jul; Vol. 99 (7), pp. 1360-1387. Date of Electronic Publication: 2024 Apr 21.
Autor:
Tefferi A; Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota, USA., Loscocco GG; Department of Experimental and Clinical Medicine, CRIMM, Center Research, and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy., Farrukh F; Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota, USA., Szuber N; Department of Hematology, Université de Montréal, Quebec, Canada., Mannelli F; Department of Experimental and Clinical Medicine, CRIMM, Center Research, and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy., Pardanani A; Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota, USA., Hanson CA; Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota, USA., Ketterling RP; Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota, USA., De Stefano V; Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Rome, Italy., Carobbio A; FROM esearch Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy., Barbui T; FROM esearch Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy., Guglielmelli P; Department of Experimental and Clinical Medicine, CRIMM, Center Research, and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy., Gangat N; Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota, USA., Vannucchi AM; Department of Experimental and Clinical Medicine, CRIMM, Center Research, and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.
Publikováno v:
American journal of hematology [Am J Hematol] 2023 Dec; Vol. 98 (12), pp. 1829-1837. Date of Electronic Publication: 2023 Sep 04.
Autor:
Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Barosi G; Department of Hematology, Center for the Study of Myelofibrosis, IRCCS Policlinico S Matteo Foundation, Pavia, Italy., Passamonti F; Dipartimento di Oncologia ed Onco-Ematologia, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Hernandez-Boluda JC; Haematology Department, Hospital Clínico Universitario, Instituto de Investigación Sanitaria, Valencia, Spain., Bose P; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Ellis M; Department of Hematology, Hematology Institute, Meir Medical Center, Tel Aviv University, Tel Aviv, Israel., Gangat N; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Gisslinger H; Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria., Gotlib J; Department of Hematology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA., Guglielmelli P; Department of Hematology, Center of Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy., Gupta V; Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Harrison C; Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Hexner EO; Cell Therapy and Transplant Program, Division of Hematology-Oncology, Department of Medicine, Philadelphia, PA., Hobbs GS; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA., Kiladjian JJ; Department of Hematology, Centre d'Investigations Cliniques Hôpital Saint-Louis, Université Paris Cité, Paris, France., Koschmieder S; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Aachen, Germany., Kroger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Kuykendall AT; Department of Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Loscocco GG; Department of Hematology, Center of Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy., Mascarenhas J; Division of Hematology and Oncology, Department of Internal Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Masarova L; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Mesa R; Department of Hematology, Levine Cancer Institute, Charlotte, NC., Mora B; Dipartimento di Oncologia ed Onco-Ematologia, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Odenike O; Department of Hematology, Leukemia Program, University of Chicago Medicine, University of Chicago Comprehensive Cancer Center, Chicago, IL., Oh ST; Division of Hematology, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO., Pardanani A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Patel A; Department of Hematology, Leukemia Program, University of Chicago Medicine, University of Chicago Comprehensive Cancer Center, Chicago, IL., Pemmaraju N; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Rambaldi A; Department of Oncology and Hematology, University of Milan, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Rampal R; Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY., Sirhan S; Department of Hematology, Jewish General Hospital, McGill University, Montreal, QC, Canada., Szuber N; Department of Hematology, Maisonneuve-Rosemont Hospital, University of Montreal, Quebec, QC, Canada., Talpaz M; Department of Hematology-Oncology, University of Michigan, Ann Arbor, MI., Vachhani PJ; Department of Medicine, Division of Hematology and Oncology, The University of Alabama at Birmingham, Birmingham, AL., Vannucchi AM; Department of Hematology, Center of Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy., Barbui T; Department of Hematology, FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
Publikováno v:
Blood [Blood] 2024 Oct 24; Vol. 144 (17), pp. 1813-1820.
Autor:
England JT; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. james.england@mail.utoronto.ca.; Division of Medical Oncology & Malignant Hematology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. james.england@mail.utoronto.ca., Szuber N; Maisonneuve-Rosemont Hospital, University of Montreal, Quebec, QC, Canada., Sirhan S; Jewish General Hospital, McGill University, Montreal, QC, Canada., Dunne T; Division of Hematology, Newfoundland and Labrador Health Services, St. John's, NL, Canada., Cerquozzi S; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada., Hill M; The Ottawa Hospital Research Institute, Ottawa, Ottawa, ON, Canada., Villeneuve PJA; The Ottawa Hospital Research Institute, Ottawa, Ottawa, ON, Canada.; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada., Ho JM; Division of Hematology, Department of Medicine, Western University, London Health Sciences Centre, London, ON, Canada., Sadikovic B; Department of Pathology and Laboratory Medicine, London Health Sciences Centre, London, ON, Canada., Bhai P; Department of Pathology and Laboratory Medicine, London Health Sciences Centre, London, ON, Canada., Krishnan N; Royal Victoria Regional Health Center, Barrie, ON, Canada., Dowhanik S; Department of Oncology, McMaster University, Hamilton, ON, Canada., Hillis C; Department of Oncology, McMaster University, Hamilton, ON, Canada., Capo-Chichi JM; Division of Clinical Laboratory Genetics, Laboratory Medicine Program, University Health Network, Toronto, ON, Canada., Tsui H; Department of Hematopathology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Cheung V; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Gauthier K; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Sibai H; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Davidson MB; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Bankar A; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Kotchetkov R; Royal Victoria Regional Health Center, Barrie, ON, Canada., Gupta V; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Maze D; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Publikováno v:
Leukemia [Leukemia] 2024 Mar; Vol. 38 (3), pp. 570-578. Date of Electronic Publication: 2024 Feb 06.
Autor:
Gangat N; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Abdallah M; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Szuber N; Department of Hematology, Université de Montréal, Montréal, Quebec, Canada., Saliba A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Alkhateeb H; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Al-Kali A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Begna KH; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Pardanani A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Tefferi A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2023 Jul; Vol. 98 (7), pp. E165-E167. Date of Electronic Publication: 2023 Apr 19.
Autor:
Gangat N; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Szuber N; Department of Hematology, Université de Montréal, Montréal, Quebec, Canada., Tefferi A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2023 Jun; Vol. 98 (6), pp. 965-981. Date of Electronic Publication: 2023 Apr 03.
Autor:
Barosi G; Center for the Study of Myelofibrosis, IRCCS Policlinico S Matteo Foundation, Pavia, Italy. Electronic address: barosig@smatteo.pv.it., Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Gangat N; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Szuber N; University of Montreal, Montreal, QC, Canada., Rambaldi A; Department of Oncology and Hematology, University of Milan and Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Odenike O; Leukemia Program, University of Chicago Medicine and University of Chicago Comprehensive Cancer Center, Chicago, IL, USA., Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Gagelmann N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Talpaz M; Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI, USA., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gale RP; Centre for Haematology, Department of Immunology and Inflammation, Imperial College of Science, Technology and Medicine, London, UK.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 May; Vol. 11 (5), pp. e383-e389. Date of Electronic Publication: 2024 Apr 08.
Autor:
Guglielmelli P; Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Division of Hematology, Azienda Ospedaliera Universitaria Careggi, Florence, Italy., Szuber N; University of Montreal, Montreal, QC, Canada.; Quebec CML-MPN Research Group, Montreal, QC, Canada.; Department of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada., Gangat N; Division of Hematology, Mayo Clinic, Rochester, MN., Capecchi G; Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Division of Hematology, Azienda Ospedaliera Universitaria Careggi, Florence, Italy., Maccari C; Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Division of Hematology, Azienda Ospedaliera Universitaria Careggi, Florence, Italy., Harnois M; Quebec CML-MPN Research Group, Montreal, QC, Canada., Karrar O; Division of Hematology, Mayo Clinic, Rochester, MN., Abdelmagid M; Division of Hematology, Mayo Clinic, Rochester, MN., Balliu M; Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Division of Hematology, Azienda Ospedaliera Universitaria Careggi, Florence, Italy., Nacca E; Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Division of Hematology, Azienda Ospedaliera Universitaria Careggi, Florence, Italy., Atanasio A; Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Division of Hematology, Azienda Ospedaliera Universitaria Careggi, Florence, Italy., Sestini I; Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Division of Hematology, Azienda Ospedaliera Universitaria Careggi, Florence, Italy., Désilets A; University of Montreal, Montreal, QC, Canada., Loscocco GG; Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Division of Hematology, Azienda Ospedaliera Universitaria Careggi, Florence, Italy., Rotunno G; Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Division of Hematology, Azienda Ospedaliera Universitaria Careggi, Florence, Italy., Busque L; University of Montreal, Montreal, QC, Canada.; Department of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada., Tefferi A; Division of Hematology, Mayo Clinic, Rochester, MN., Vannucchi AM; Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Division of Hematology, Azienda Ospedaliera Universitaria Careggi, Florence, Italy.
Publikováno v:
Blood [Blood] 2024 Mar 28; Vol. 143 (13), pp. 1310-1314.
Autor:
Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA., Ianotto JC; Department of Clinical Hematology, University Hospital of Brest, Brest, France., Mathews V; Department of Haematology, Christian Medical College, Vellore, Tamil Nadu, India., Samuelsson J; Department of Hematology, Linköping University Hospital, Linköping, Sweden., Szuber N; Department of Hematology, Maisonneuve-Rosemont Hospital, Montreal, Canada., Xiao Z; MDS and MPN Centre, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China., Hokland P; Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark.
Publikováno v:
British journal of haematology [Br J Haematol] 2022 Sep; Vol. 198 (6), pp. 953-964. Date of Electronic Publication: 2022 Apr 28.
Autor:
Tefferi A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Szuber N; Department of Hematology, Université de Montréal, Montréal, Quebec, Canada., Pardanani A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Hanson CA; Division of Hematopathology, Department of Laboratory Medicine, Mayo Clinic, Rochester, Minnesota, USA., Vannucchi AM; Department of Experimental and Clinical Medicine, CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy., Barbui T; Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy., Gangat N; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2021 Jun 01; Vol. 96 (6), pp. E182-E184. Date of Electronic Publication: 2021 Mar 11.